Literature DB >> 11898350

The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice.

T Hudcovic1, R Stĕpánková, J Cebra, H Tlaskalová-Hogenová.   

Abstract

One-week dextran sulfate treatment of conventional (CV) immunodeficient (SCID) mice gave rise to acute colitis in the colon mucosa; germ-free (GF) SCID mice did not exhibit any changes in colon morphology. Dextran sulfate application to CV immunocompetent (BALB/c) mice did induce substantial changes in the colon mucosa (grade 4); GF BALB/c mice showed mild changes in the colon morphology (grade 1) only. GF SCID mice and CV SCID mice died during the second round of dextran sulfate treatment suffering from chronic colitis; GF BALB/c mice exhibited mild crypt distortion while CV BALB/c mice showed a complete loss of the surface epithelium (grade 4), accompanied by T and B lymphocyte infiltration.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11898350     DOI： 10.1007/bf02818004

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


  21 in total

1.  Differences in development of lymphocyte subpopulations from gut-associated lymphatic tissue (GALT) of germfree and conventional rats: effect of aging.

Authors:  R Stĕpánková; J Sinkora; T Hudcovic; H Kozáková; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

Review 2.  Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice.

Authors:  W Strober; R O Ehrhardt
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

3.  Experimental models of inflammatory bowel disease.

Authors:  E Louis; J Belaiche
Journal:  Acta Gastroenterol Belg       Date:  1994 Sep-Dec       Impact factor: 1.316

4.  Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes.

Authors:  J Ni; S F Chen; D Hollander
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

5.  Oral administration of antigens from intestinal flora anaerobic bacteria reduces the severity of experimental acute colitis in BALB/c mice.

Authors:  E F Verdù; P Bercik; B Cukrowska; M A Farre-Castany; H Bouzourene; E Saraga; A L Blum; I Corthésy-Theulaz; H Tlaskalova-Hogenova; P Michetti
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

6.  The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice.

Authors:  W Hans; J Schölmerich; V Gross; W Falk
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-03       Impact factor: 2.566

7.  Proliferative effect of dextran sulfate sodium (DSS)-pulsed macrophages on T cells from mice with DSS-induced colitis and inhibition of effect by IgG.

Authors:  N Shintani; T Nakajima; M Sugiura; K Murakami; N Nakamura; Y Kagitani; T Mayumi
Journal:  Scand J Immunol       Date:  1997-12       Impact factor: 3.487

Review 8.  Autoimmunity, immunodeficiency and mucosal infections: chronic intestinal inflammation as a sensitive indicator of immunoregulatory defects in response to normal luminal microflora.

Authors:  H Tlaskalová-Hogenová; R Stĕpánková; L Tucková; M A Farré; D P Funda; E F Verdú; J Sinkora; T Hudcovic; Z Reháková; B Cukrowska; H Kozáková; L Prokesová
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

9.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

10.  Carrageenan-induced ulceration of the large intestine in the guinea pig.

Authors:  J Watt; R Marcus
Journal:  Gut       Date:  1971-02       Impact factor: 23.059
View more
  46 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Intestinal alkaline phosphatase has beneficial effects in mouse models of chronic colitis.

Authors:  Sundaram Ramasamy; Deanna D Nguyen; Michelle A Eston; Sayeda Nasrin Alam; Angela K Moss; Farzad Ebrahimi; Brishti Biswas; Golam Mostafa; Kathryn T Chen; Kanakaraju Kaliannan; Halim Yammine; Sonoko Narisawa; José Luis Millán; H Shaw Warren; Elizabeth L Hohmann; Emiko Mizoguchi; Hans-Christian Reinecker; Atul K Bhan; Scott B Snapper; Madhu S Malo; Richard A Hodin
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

Review 3.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

4.  Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation.

Authors:  Mélanie G Gareau; Jennifer Jury; Glenda MacQueen; Philip M Sherman; Mary H Perdue
Journal:  Gut       Date:  2007-03-05       Impact factor: 23.059

5.  Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice.

Authors:  A Kokesová; L Frolová; M Kverka; D Sokol; P Rossmann; J Bártová; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 6.  Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.

Authors:  Nina A Hering; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

Review 7.  Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

Authors:  Larissa S Celiberto; Franziska A Graef; Genelle R Healey; Else S Bosman; Kevan Jacobson; Laura M Sly; Bruce A Vallance
Journal:  Immunology       Date:  2018-05-16       Impact factor: 7.397

8.  Chemically induced mouse models of acute and chronic intestinal inflammation.

Authors:  Stefan Wirtz; Vanessa Popp; Markus Kindermann; Katharina Gerlach; Benno Weigmann; Stefan Fichtner-Feigl; Markus F Neurath
Journal:  Nat Protoc       Date:  2017-06-01       Impact factor: 13.491

9.  Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

Authors:  Lenka Frol'ová; Karel Smetana; Dana Borovská; Andrea Kitanovicová; Klára Klimesová; Ivana Janatková; Karin Malícková; Milan Lukás; Pavel Drastich; Zdenek Benes; Ludmila Tucková; Joachim C Manning; Sabine André; Hans-Joachim Gabius; Helena Tlaskalová-Hogenová
Journal:  Inflamm Res       Date:  2009-03-07       Impact factor: 4.575

10.  Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases.

Authors:  Marie-Alexandra Alyanakian; Sylvaine You; Diane Damotte; Christine Gouarin; Anne Esling; Corinne Garcia; Séverine Havouis; Lucienne Chatenoud; Jean-François Bach
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.